BLFS - Biolife Solutions Inc
IEX Last Trade
25.87
-0.050 -0.193%
Share volume: 394,425
Last Updated: Fri 30 Aug 2024 09:59:50 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.87%
PREVIOUS CLOSE
CHG
CHG%
$25.92
-0.05
-0.19%
View ratios
| Fiscal Date | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | |
| Report Date | 2022-05-10 | 2022-08-09 | 2022-11-09 | 2023-03-31 | 2023-05-11 | 2023-08-09 | 2023-11-09 | 2024-02-29 | |
| Total revenue | 36.220 M | 40.533 M | 40.747 M | 44.259 M | 37.703 M | 39.508 M | 33.328 M | 32.732 M | |
| Cost of revenue | 24.446 M | 26.194 M | 27.009 M | 30.288 M | 23.664 M | 27.696 M | 21.679 M | 23.480 M | |
| Gross profit | 11.774 M | 14.339 M | 13.738 M | 13.971 M | 14.039 M | 11.812 M | 11.649 M | 9.252 M | |
| 21.79% | -4.19% | 1.70% | 0.49% | -15.86% | -1.38% | -20.58% | |||
| Operating expenses | 19.868 M | 20.194 M | 20.283 M | 23.693 M | 25.465 M | 26.560 M | 25.171 M | 21.908 M | |
| Selling general and admin | 16.087 M | 16.766 M | 16.858 M | 19.529 M | 21.313 M | 21.720 M | 19.769 M | 17.506 M | |
| Research and development | 3.781 M | 3.428 M | 3.425 M | 4.164 M | 4.152 M | 4.840 M | 5.402 M | 4.402 M | |
| Total expenses | 47.177 M | 49.251 M | 49.805 M | 55.439 M | 50.588 M | 55.706 M | 48.206 M | 46.304 M | |
| 4.40% | 1.12% | 11.31% | -8.75% | 10.12% | -13.46% | -3.95% | |||
| Operating income | -10.957 M | -8.718 M | -9.058 M | -11.180 M | -12.885 M | -16.198 M | -14.878 M | -13.572 M | |
| Ebit | -10.957 M | -8.718 M | -9.058 M | -11.180 M | -12.885 M | -16.198 M | -14.878 M | -13.572 M | |
| Pretax income | -7.665 M | -76.293 M | -10.556 M | -50.313 M | -13.622 M | -10.194 M | -29.017 M | -13.425 M | |
| 895.34% | -86.16% | 376.63% | -72.93% | -25.17% | 184.65% | -53.73% | |||
| Income tax | -599.000 K | -3.739 M | -599.000 K | -85.000 K | 92.000 K | 5.000 K | 115.000 K | -43.000 K | |
| Net income basic | -7.066 M | -72.554 M | -9.957 M | -50.228 M | -13.714 M | -10.199 M | -29.132 M | -13.382 M | |
| -926.80% | 86.28% | -404.45% | 72.70% | 25.63% | -185.64% | 54.06% | |||
| Net income | -7.066 M | -72.554 M | -9.957 M | -50.228 M | -13.714 M | -10.199 M | -29.132 M | -13.382 M | |
| -926.80% | 86.28% | -404.45% | 72.70% | 25.63% | -185.64% | 54.06% |